Arthritis Breakthrough that Activates the Gene Responsible for Regenerating Cartilage Enters Clinical Trials

Arthritis Breakthrough that Activates the Gene Responsible for Regenerating Cartilage Enters Clinical Trials The clinical study being conducted by clinical research organization Santerra Pharmaceuticals, LLC was submitted to Current Controlled Trials for review of the protocol and assignment of an International Standardized Randomized Controlled Trial Number (ISRCTN25438351).
Home Naturade Significantly Strengthens Balance Sheet; Receives $2.5 Million in Capital from Westgate Equity Partners, L.P. Natrol Appoints Vincent Andrich VP Sales for Prolab Division Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results Body Shop Reports 24.8 Mil Euro Sales Revenues Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label Supplement Group Targets Consumer Education Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO drugstore.com Expects to Reach Profitability Target in 2003 Human Genome Project Leads to Innovative Healthcare NPIcenter’s Career Center targets nutraceutical Industry Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders Editorial: An Exercise in Synergy NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway Natural Health Trends Corp. Launches Lexxus Taiwan FDA Presents Compliance Guide for Structure/Function Claims New TrimFit® Bars Redefine Energy Bar Category New TrimFit® Bars Redefine Energy Bar Category Probiata® Offers Safe, Natural and Effective Alternative Alive & Well with Michelle Harris Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com Consumers Search for Healthy Cleaning Products That Work Nordic Naturals: Omega 3 Fatty Acids Cyanotech Names Bob Capelli as Director of Sales Traditional Chinese Medicine For Diabetes Has Scientific Backing A collaboration between Chinese, Korean, and Australian scientists at Sydney's Garvan Institute, has revealed that the natural plant product berberine could be a valuable new treatment for people suffering from type 2 diabetes. Traditional Chinese Medicine For Diabetes Has Scientific Backing A collaboration between Chinese, Korean, and Australian scientists at Sydney's Garvan Institute, has revealed that the natural plant product berberine could be a valuable new treatment for people suffering from type 2 diabetes. Traditional Chinese Medicine For Diabetes Has Scientific Backing A collaboration between Chinese, Korean, and Australian scientists at Sydney's Garvan Institute, has revealed that the natural plant product berberine could be a valuable new treatment for people suffering from type 2 diabetes. Traditional Chinese Medicine For Diabetes Has Scientific Backing A collaboration between Chinese, Korean, and Australian scientists at Sydney's Garvan Institute, has revealed that the natural plant product berberine could be a valuable new treatment for people suffering from type 2 diabetes. Traditional Chinese Medicine For Diabetes Has Scientific Backing A collaboration between Chinese, Korean, and Australian scientists at Sydney's Garvan Institute, has revealed that the natural plant product berberine could be a valuable new treatment for people suffering from type 2 diabetes. UCLA study shows altering fatty acid levels in diet may reduce prostate cancer growth rate UCLA researchers, in an animal study published in the Aug. 1 issue of the journal Clinical Cancer Research, have found that altering the fatty acid ratio found in the typical Western diet to include more omega-3 fatty acids and decrease the amount of omega-6 fatty acids may reduce prostate cancer tumor growth rates and PSA levels. UCLA study shows altering fatty acid levels in diet may reduce prostate cancer growth rate UCLA researchers, in an animal study published in the Aug. 1 issue of the journal Clinical Cancer Research, have found that altering the fatty acid ratio found in the typical Western diet to include more omega-3 fatty acids and decrease the amount of omega-6 fatty acids may reduce prostate cancer tumor growth rates and PSA levels. UCLA study shows altering fatty acid levels in diet may reduce prostate cancer growth rate UCLA researchers, in an animal study published in the Aug. 1 issue of the journal Clinical Cancer Research, have found that altering the fatty acid ratio found in the typical Western diet to include more omega-3 fatty acids and decrease the amount of omega-6 fatty acids may reduce prostate cancer tumor growth rates and PSA levels. UCLA study shows altering fatty acid levels in diet may reduce prostate cancer growth rate UCLA researchers, in an animal study published in the Aug. 1 issue of the journal Clinical Cancer Research, have found that altering the fatty acid ratio found in the typical Western diet to include more omega-3 fatty acids and decrease the amount of omega-6 fatty acids may reduce prostate cancer tumor growth rates and PSA levels. Study Indicates LJ100 Eurycoma longifolia extract Safely Promotes Anabolic Balance During Endurance Exercise Study entitled, “Effect of Eurycoma longifolia Extract on Anabolic Balance During Endurance Exercise,” indicates that Eurycoma longifolia extract, standardized to 40% glycosaponins and 22% eurypeptides, was associated with a 33% decrease in cortisol levels and an increase in testosterone levels of 16.4%. Study Indicates LJ100 Eurycoma longifolia extract Safely Promotes Anabolic Balance During Endurance Exercise Study entitled, “Effect of Eurycoma longifolia Extract on Anabolic Balance During Endurance Exercise,” indicates that Eurycoma longifolia extract, standardized to 40% glycosaponins and 22% eurypeptides, was associated with a 33% decrease in cortisol levels and an increase in testosterone levels of 16.4%. Study Indicates LJ100 Eurycoma longifolia extract Safely Promotes Anabolic Balance During Endurance Exercise Study entitled, “Effect of Eurycoma longifolia Extract on Anabolic Balance During Endurance Exercise,” indicates that Eurycoma longifolia extract, standardized to 40% glycosaponins and 22% eurypeptides, was associated with a 33% decrease in cortisol levels and an increase in testosterone levels of 16.4%. New Study Provides Antioxidant Concentration for More Than 1,000 Foods and Beverages A study, published in the American Journal of Clinical Nutrition, provides a listing of the total concentration of antioxidants (assessed using the FRAP (ferric reducing ability of plasma) assay method) for more than 1,000 foods and beverages commonly consumed in the U.S. New Study Provides Antioxidant Concentration for More Than 1,000 Foods and Beverages A study, published in the American Journal of Clinical Nutrition, provides a listing of the total concentration of antioxidants (assessed using the FRAP (ferric reducing ability of plasma) assay method) for more than 1,000 foods and beverages commonly consumed in the U.S. David Cai, Ph.D., Joins Cognis as Senior Scientist David Cai, Ph.D., has joined Cognis Nutrition & Health as Senior Scientist responsible for managing scientific research projects in North America for Cognis’ portfolio of ingredients used in functional foods and dietary supplements. David Cai, Ph.D., Joins Cognis as Senior Scientist David Cai, Ph.D., has joined Cognis Nutrition & Health as Senior Scientist responsible for managing scientific research projects in North America for Cognis’ portfolio of ingredients used in functional foods and dietary supplements. David Cai, Ph.D., Joins Cognis as Senior Scientist David Cai, Ph.D., has joined Cognis Nutrition & Health as Senior Scientist responsible for managing scientific research projects in North America for Cognis’ portfolio of ingredients used in functional foods and dietary supplements. David Cai, Ph.D., Joins Cognis as Senior Scientist David Cai, Ph.D., has joined Cognis Nutrition & Health as Senior Scientist responsible for managing scientific research projects in North America for Cognis’ portfolio of ingredients used in functional foods and dietary supplements. David Cai, Ph.D., Joins Cognis as Senior Scientist David Cai, Ph.D., has joined Cognis Nutrition & Health as Senior Scientist responsible for managing scientific research projects in North America for Cognis’ portfolio of ingredients used in functional foods and dietary supplements. David Cai, Ph.D., Joins Cognis as Senior Scientist David Cai, Ph.D., has joined Cognis Nutrition & Health as Senior Scientist responsible for managing scientific research projects in North America for Cognis’ portfolio of ingredients used in functional foods and dietary supplements. Compound in dairy products targets diabetes According to a researcher at Penn State, fatty acids commonly found in dairy products, known as conjugated linoleic acids (CLA), ave successfully treated diabetes in mice and have also shown promising results in human trials. Compound in dairy products targets diabetes According to a researcher at Penn State, fatty acids commonly found in dairy products, known as conjugated linoleic acids (CLA), ave successfully treated diabetes in mice and have also shown promising results in human trials. Compound in dairy products targets diabetes According to a researcher at Penn State, fatty acids commonly found in dairy products, known as conjugated linoleic acids (CLA), ave successfully treated diabetes in mice and have also shown promising results in human trials. Compound in dairy products targets diabetes According to a researcher at Penn State, fatty acids commonly found in dairy products, known as conjugated linoleic acids (CLA), ave successfully treated diabetes in mice and have also shown promising results in human trials. Compound in dairy products targets diabetes According to a researcher at Penn State, fatty acids commonly found in dairy products, known as conjugated linoleic acids (CLA), ave successfully treated diabetes in mice and have also shown promising results in human trials. New Study Published in Diabetes Care Shows that Supplementation with Chromium Picolinate Significantly Improves Glycemic Control and Attenuates Weight Gain Results from a new study, conducted by researchers at Pennington Biomedical Research Center (PBRC) and the University of Vermont College of Medicine, and published in the August issue of Diabetes Care, in patients with type 2 diabetes demonstrate that daily supplementation with 1000 mcg of chromium as chromium picolinate, in combination with a common oral anti-diabetic medication, improves insulin sensitivity and glucose control better than the oral anti-diabetic agent alone. New Study Published in Diabetes Care Shows that Supplementation with Chromium Picolinate Significantly Improves Glycemic Control and Attenuates Weight Gain Results from a new study, conducted by researchers at Pennington Biomedical Research Center (PBRC) and the University of Vermont College of Medicine, and published in the August issue of Diabetes Care, in patients with type 2 diabetes demonstrate that daily supplementation with 1000 mcg of chromium as chromium picolinate, in combination with a common oral anti-diabetic medication, improves insulin sensitivity and glucose control better than the oral anti-diabetic agent alone. New Study Published in Diabetes Care Shows that Supplementation with Chromium Picolinate Significantly Improves Glycemic Control and Attenuates Weight Gain Results from a new study, conducted by researchers at Pennington Biomedical Research Center (PBRC) and the University of Vermont College of Medicine, and published in the August issue of Diabetes Care, in patients with type 2 diabetes demonstrate that daily supplementation with 1000 mcg of chromium as chromium picolinate, in combination with a common oral anti-diabetic medication, improves insulin sensitivity and glucose control better than the oral anti-diabetic agent alone. New Study Published in Diabetes Care Shows that Supplementation with Chromium Picolinate Significantly Improves Glycemic Control and Attenuates Weight Gain Results from a new study, conducted by researchers at Pennington Biomedical Research Center (PBRC) and the University of Vermont College of Medicine, and published in the August issue of Diabetes Care, in patients with type 2 diabetes demonstrate that daily supplementation with 1000 mcg of chromium as chromium picolinate, in combination with a common oral anti-diabetic medication, improves insulin sensitivity and glucose control better than the oral anti-diabetic agent alone. New Study Published in Diabetes Care Shows that Supplementation with Chromium Picolinate Significantly Improves Glycemic Control and Attenuates Weight Gain Results from a new study, conducted by researchers at Pennington Biomedical Research Center (PBRC) and the University of Vermont College of Medicine, and published in the August issue of Diabetes Care, in patients with type 2 diabetes demonstrate that daily supplementation with 1000 mcg of chromium as chromium picolinate, in combination with a common oral anti-diabetic medication, improves insulin sensitivity and glucose control better than the oral anti-diabetic agent alone. Research Supports Cyclist Benefits From PeptoPro(R) Recent studies conducted in the Human Performance Laboratory at James Madison University have revealed that cyclists who consumed beverages enriched with PeptoPro® during time trials clocked faster times and had reduced muscle soreness post-activity compared with those drinking traditional, carbohydrate-only sports drinks. Research Supports Cyclist Benefits From PeptoPro(R) Recent studies conducted in the Human Performance Laboratory at James Madison University have revealed that cyclists who consumed beverages enriched with PeptoPro® during time trials clocked faster times and had reduced muscle soreness post-activity compared with those drinking traditional, carbohydrate-only sports drinks. Research Supports Cyclist Benefits From PeptoPro(R) Recent studies conducted in the Human Performance Laboratory at James Madison University have revealed that cyclists who consumed beverages enriched with PeptoPro® during time trials clocked faster times and had reduced muscle soreness post-activity compared with those drinking traditional, carbohydrate-only sports drinks. Research Supports Cyclist Benefits From PeptoPro(R) Recent studies conducted in the Human Performance Laboratory at James Madison University have revealed that cyclists who consumed beverages enriched with PeptoPro® during time trials clocked faster times and had reduced muscle soreness post-activity compared with those drinking traditional, carbohydrate-only sports drinks. Research Supports Cyclist Benefits From PeptoPro(R) Recent studies conducted in the Human Performance Laboratory at James Madison University have revealed that cyclists who consumed beverages enriched with PeptoPro® during time trials clocked faster times and had reduced muscle soreness post-activity compared with those drinking traditional, carbohydrate-only sports drinks. Advitech Announces Positive Results For a Third Application Of The XP-828L Platform and Publication Of a Second Scientific Paper On Dermylex Company announces the preliminary results on Atopic Dermatitis (AD), a third potential application originating from its XP-828L platform. Advitech Announces Positive Results For a Third Application Of The XP-828L Platform and Publication Of a Second Scientific Paper On Dermylex Company announces the preliminary results on Atopic Dermatitis (AD), a third potential application originating from its XP-828L platform. Study Shows Addition of Protein to a Sports Drink Dramatically Improves Rehydration A protein-containing sports drink was 15 percent more effective in rehydrating athletes than a conventional sports drink and 40 percent more effective than water, according to a new study reported in the August 2006 issue of International Journal of Sport Nutrition and Exercise Metabolism (IJSNEM). Study Shows Addition of Protein to a Sports Drink Dramatically Improves Rehydration A protein-containing sports drink was 15 percent more effective in rehydrating athletes than a conventional sports drink and 40 percent more effective than water, according to a new study reported in the August 2006 issue of International Journal of Sport Nutrition and Exercise Metabolism (IJSNEM). Study Shows Addition of Protein to a Sports Drink Dramatically Improves Rehydration A protein-containing sports drink was 15 percent more effective in rehydrating athletes than a conventional sports drink and 40 percent more effective than water, according to a new study reported in the August 2006 issue of International Journal of Sport Nutrition and Exercise Metabolism (IJSNEM). Study Shows Addition of Protein to a Sports Drink Dramatically Improves Rehydration A protein-containing sports drink was 15 percent more effective in rehydrating athletes than a conventional sports drink and 40 percent more effective than water, according to a new study reported in the August 2006 issue of International Journal of Sport Nutrition and Exercise Metabolism (IJSNEM). Study Shows Addition of Protein to a Sports Drink Dramatically Improves Rehydration A protein-containing sports drink was 15 percent more effective in rehydrating athletes than a conventional sports drink and 40 percent more effective than water, according to a new study reported in the August 2006 issue of International Journal of Sport Nutrition and Exercise Metabolism (IJSNEM). New Study: CLA May Serve Critical Role in Preventing Weight and Fat Gain During Year-End Holidays and with Normal Aging A new study published online in the International Journal of Obesity suggests that Tonalin® CLA could have long-term health benefits by preventing weight and fat gain commonly experienced by adults during the November-December holiday season, and in the normal aging process. New Study: CLA May Serve Critical Role in Preventing Weight and Fat Gain During Year-End Holidays and with Normal Aging A new study published online in the International Journal of Obesity suggests that Tonalin® CLA could have long-term health benefits by preventing weight and fat gain commonly experienced by adults during the November-December holiday season, and in the normal aging process. New Study: CLA May Serve Critical Role in Preventing Weight and Fat Gain During Year-End Holidays and with Normal Aging A new study published online in the International Journal of Obesity suggests that Tonalin® CLA could have long-term health benefits by preventing weight and fat gain commonly experienced by adults during the November-December holiday season, and in the normal aging process. New Study: CLA May Serve Critical Role in Preventing Weight and Fat Gain During Year-End Holidays and with Normal Aging A new study published online in the International Journal of Obesity suggests that Tonalin® CLA could have long-term health benefits by preventing weight and fat gain commonly experienced by adults during the November-December holiday season, and in the normal aging process. New Study: CLA May Serve Critical Role in Preventing Weight and Fat Gain During Year-End Holidays and with Normal Aging A new study published online in the International Journal of Obesity suggests that Tonalin® CLA could have long-term health benefits by preventing weight and fat gain commonly experienced by adults during the November-December holiday season, and in the normal aging process. New Study: CLA May Serve Critical Role in Preventing Weight and Fat Gain During Year-End Holidays and with Normal Aging A new study published online in the International Journal of Obesity suggests that Tonalin® CLA could have long-term health benefits by preventing weight and fat gain commonly experienced by adults during the November-December holiday season, and in the normal aging process. GliSODin study on oxidative stress in immune compromised humans included in the 2006 XVI International AIDS Conference A study on Glisodin and immune compromised individuals at the AIDS 2006 - XVI International AIDS Conference, August 13-18 2006, held in Toronto. In the study, Glisodin was shown to restore the circulating antioxidant capacities, including Superoxide Dismustase (SOD), in the Glisodin group, compared to no change in the control and placebo group. GliSODin study on oxidative stress in immune compromised humans included in the 2006 XVI International AIDS Conference A study on Glisodin and immune compromised individuals at the AIDS 2006 - XVI International AIDS Conference, August 13-18 2006, held in Toronto. In the study, Glisodin was shown to restore the circulating antioxidant capacities, including Superoxide Dismustase (SOD), in the Glisodin group, compared to no change in the control and placebo group. GliSODin study on oxidative stress in immune compromised humans included in the 2006 XVI International AIDS Conference A study on Glisodin and immune compromised individuals at the AIDS 2006 - XVI International AIDS Conference, August 13-18 2006, held in Toronto. In the study, Glisodin was shown to restore the circulating antioxidant capacities, including Superoxide Dismustase (SOD), in the Glisodin group, compared to no change in the control and placebo group. GliSODin study on oxidative stress in immune compromised humans included in the 2006 XVI International AIDS Conference A study on Glisodin and immune compromised individuals at the AIDS 2006 - XVI International AIDS Conference, August 13-18 2006, held in Toronto. In the study, Glisodin was shown to restore the circulating antioxidant capacities, including Superoxide Dismustase (SOD), in the Glisodin group, compared to no change in the control and placebo group. Vanderbilt-Ingram Cancer Center researchers find ginseng may improve breast cancer outcomes Study by Vanderbilt-Ingram Cancer Center researchers, published online recently in the American Journal of Epidemiology, indicates that ginseng may improve survival and quality of life after a diagnosis of breast cancer Vanderbilt-Ingram Cancer Center researchers find ginseng may improve breast cancer outcomes Study by Vanderbilt-Ingram Cancer Center researchers, published online recently in the American Journal of Epidemiology, indicates that ginseng may improve survival and quality of life after a diagnosis of breast cancer Vanderbilt-Ingram Cancer Center researchers find ginseng may improve breast cancer outcomes Study by Vanderbilt-Ingram Cancer Center researchers, published online recently in the American Journal of Epidemiology, indicates that ginseng may improve survival and quality of life after a diagnosis of breast cancer Vanderbilt-Ingram Cancer Center researchers find ginseng may improve breast cancer outcomes Study by Vanderbilt-Ingram Cancer Center researchers, published online recently in the American Journal of Epidemiology, indicates that ginseng may improve survival and quality of life after a diagnosis of breast cancer Broccoli Extract Studies Available on Web Much of the research published on the positive beneficial effects of broccoli’s active component glucoraphanin and its hydrolyzed product sulforphane is available on the web site www.yoursgsmed.com. Broccoli Extract Studies Available on Web Much of the research published on the positive beneficial effects of broccoli’s active component glucoraphanin and its hydrolyzed product sulforphane is available on the web site www.yoursgsmed.com. Broccoli Extract Studies Available on Web Much of the research published on the positive beneficial effects of broccoli’s active component glucoraphanin and its hydrolyzed product sulforphane is available on the web site www.yoursgsmed.com. Broccoli Extract Studies Available on Web Much of the research published on the positive beneficial effects of broccoli’s active component glucoraphanin and its hydrolyzed product sulforphane is available on the web site www.yoursgsmed.com. New Data Demonstrates Minimal Interactions Between Omacor(R) (Omega-3-Acid Ethyl Esters) and Simvastatin Data in the July edition of the Journal of Clinical Pharmacology indicates that co-administration of Omacor (omega-3-acid ethyl esters) (4 g) with simvastatin (80 mg) has minimal interaction between the two drugs. New Data Demonstrates Minimal Interactions Between Omacor(R) (Omega-3-Acid Ethyl Esters) and Simvastatin Data in the July edition of the Journal of Clinical Pharmacology indicates that co-administration of Omacor (omega-3-acid ethyl esters) (4 g) with simvastatin (80 mg) has minimal interaction between the two drugs. New Data Demonstrates Minimal Interactions Between Omacor(R) (Omega-3-Acid Ethyl Esters) and Simvastatin Data in the July edition of the Journal of Clinical Pharmacology indicates that co-administration of Omacor (omega-3-acid ethyl esters) (4 g) with simvastatin (80 mg) has minimal interaction between the two drugs. New Data Demonstrates Minimal Interactions Between Omacor(R) (Omega-3-Acid Ethyl Esters) and Simvastatin Data in the July edition of the Journal of Clinical Pharmacology indicates that co-administration of Omacor (omega-3-acid ethyl esters) (4 g) with simvastatin (80 mg) has minimal interaction between the two drugs. New Data Demonstrates Minimal Interactions Between Omacor(R) (Omega-3-Acid Ethyl Esters) and Simvastatin Data in the July edition of the Journal of Clinical Pharmacology indicates that co-administration of Omacor (omega-3-acid ethyl esters) (4 g) with simvastatin (80 mg) has minimal interaction between the two drugs. Study Shows the Effectiveness of Oral Probiotic L. Rhamnosus GR-1™ and L. Reuteri RC-14™ In Treating Bacterial Vaginosis Study published in Microbes and Infection demonstrated that the probiotic strains Lactobacillus rhamnosus GR-1™ and Lactobacillus reuteri RC-14™ were efficacious in treating bacterial vaginosis (BV) and increasing the population of beneficial lactobacillus organisms within the vagina. Study Shows the Effectiveness of Oral Probiotic L. Rhamnosus GR-1™ and L. Reuteri RC-14™ In Treating Bacterial Vaginosis Study published in Microbes and Infection demonstrated that the probiotic strains Lactobacillus rhamnosus GR-1™ and Lactobacillus reuteri RC-14™ were efficacious in treating bacterial vaginosis (BV) and increasing the population of beneficial lactobacillus organisms within the vagina. Study Shows the Effectiveness of Oral Probiotic L. Rhamnosus GR-1™ and L. Reuteri RC-14™ In Treating Bacterial Vaginosis Study published in Microbes and Infection demonstrated that the probiotic strains Lactobacillus rhamnosus GR-1™ and Lactobacillus reuteri RC-14™ were efficacious in treating bacterial vaginosis (BV) and increasing the population of beneficial lactobacillus organisms within the vagina. Study Shows the Effectiveness of Oral Probiotic L. Rhamnosus GR-1™ and L. Reuteri RC-14™ In Treating Bacterial Vaginosis Study published in Microbes and Infection demonstrated that the probiotic strains Lactobacillus rhamnosus GR-1™ and Lactobacillus reuteri RC-14™ were efficacious in treating bacterial vaginosis (BV) and increasing the population of beneficial lactobacillus organisms within the vagina. Study: BioGaia´s Probiotic Oil Drops Halve Hospital Stay A study involving 184 premature infants admitted to the neonatal intensive care unit immediately after delivery allocated the infants to one of three groups: 67 infants received BioGaia Reuteri Drops containing Lactobacillus reuteri Protectis (Reuteri), 55 infants received Lactobacilus rhamnosus GG (LGG), i.e. another probiotic, and 62 infants were treated only with the normal treatment (control group). In both the groups that received daily probiotics, the risk of infection by yeast (Candida) was reduced as was the incidence of bacterial infections. The Reuteri group had also further effects such as reduced occurrence of gastro-intestinal symptoms, earlier tolerance of food by mouth (intravenous nutrition could be stopped earlier), reduced weight loss during the first week of life, better growth during the first month of life and fewer days of hospitalisation. Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology. Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology. Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Heart Health Alert: Niacin May Reverse Hardening of the Arteries Heart Health Alert: Niacin May Reverse Hardening of the Arteries Heart Health Alert: Niacin May Reverse Hardening of the Arteries Heart Health Alert: Niacin May Reverse Hardening of the Arteries Spotlight on Savory Side Dishes Spotlight on Savory Side Dishes Spotlight on Savory Side Dishes Another Reason to Choose Healthy Lifestyle Habits Another Reason to Choose Healthy Lifestyle Habits	Raleigh, NC. – Reparagen(TM), a breakthrough in managing arthritis and joint damage which in lab tests was shown to activate a critical repair gene, IGF-1 in human cartilage while blocking joint destruction associated with inflammation, has now entered clinical trials. The clinical study being conducted by clinical research organization Santerra Pharmaceuticals, LLC (www.santerra-pharma.com) was submitted to Current Controlled Trials for review of the protocol and assignment of an International Standardized Randomized Controlled Trial Number (ISRCTN25438351). Both Santerra and Rainforest Nutritionals believe in the importance of exemplary science performed in open access manner and details of this 8 week clinical study in 80 subjects can be found at http://www.controlled-trials.com/ISRCTN25438351. Mark J.S. Miller, Ph.D., M.B.A., Professor of Cardiovascular Sciences and Pediatrics at Albany Medical College (NY) and head of the Scientific Advisory Board said that, “This trial is important because it directly compares Reparagen with glucosamine in treating subjects with moderate osteoarthritis. Glucosamine is both familiar to consumers and is currently a gold standard in the natural product approach to osteoarthritis although recent studies have described its limitations and the need for effective alternatives.” The clinical trial will compare Reparagen versus glucosamine in a variety of pain, mobility and functional assessments in subjects with moderate osteoarthritis of the knee. Prior to this clinical investigation Reparagen was found to be the first natural product to “silence” genes that promote joint damage while simultaneously activating the repair gene, IGF-1, in human chondrocytes. This research was published in the open access journal BMC Complementary & Alternative Medicine (http://www.biomedcentral.com/1472-6882/6/13). Rainforest Nutritionals, Inc. Vice President Paul Bobrowski emphasized that, “Reparagen continues to set a new standard in the joint health market, emphasized by this clinical study and the Current Controlled Trials validation.” Elaborating Bobrowski said, “We believe that Reparagen’s unique action and its NIH innovation Award makes it the alternative to glucosamine or chondroitin that consumers are seeking”. About Rainforest Nutritionals, Inc Founded in 2002, Rainforest Nutritionals, Inc. (www.rainforest-inc.com) is dedicated to the development of innovative natural therapeutics for the business to business market. About Santerra Pharmaceuticals, LLC Santerra Pharmaceuticals, LLC is a contract research organization that specializes in scientific and clinical support for companies active in the natural products sector. For further information visit www.reparagen.com or call 1-866-795-7246.
Powered By Traffic Booster Absolute News Manager Plug-in by Xigla Software